Medication Monitor



Generic Name (Trade Name—Company)
Notes
October 21, 2011

Oxymetazoline

(Nostrilla Nasal Decongestant—Insight Pharmaceuticals)
Bacterial contamination prompts recall

A single lot of Nostrilla Nasal Decongestant nasal spray (Lot #11G075, UPC Code 6373673005) is being recalled to the consumer level because it may contain the bacteria Burkholderia cepacia, according to FDA. The recall was initiated following internal investigations that determined the potential presence of a microbial contaminant exceeding the product specifications. Burkholderia cepacia may cause serious infection in immunocompromised patients or those with chronic lung conditions. The chances of an infection in healthy patients is minimal.

The product was distributed nationwide to retail stores and pharmacies. It is packaged in 0.5-ounce plastic bottles with an expiration date of 05/2014 stamped on the side.

No illnesses have been reported to date in connection with this problem. Patients who purchased the product are urged to return it and contact the company at 877-546-9059.